BIA
GMAB icon

Bell Investment Advisors’s Genmab GMAB Stock Holding History

Bell Investment Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$907 Sell
33
-303
-90% -$8.05K ﹤0.01% 1552
2026
Q1 		$9.02K Buy
336
+45
+15% +$1.35K ﹤0.01% 716
2025
Q4 		$8.96K Buy
291
+186
+177% +$5.8K ﹤0.01% 732
2025
Q3 		$3.22K Sell
105
-59
-36% -$1.44K ﹤0.01% 1127
2025
Q2 		$3.39K Buy
164
+84
+105% +$1.72K ﹤0.01% 1151
2025
Q1 		$1.57K Buy
80
+44
+122% +$923 ﹤0.01% 1398
2024
Q4 		$752 Hold
36
– – ﹤0.01% 1672
2024
Q3 		$878 Sell
36
-20
-36% -$535 ﹤0.01% 1632
2024
Q2 		$1.41K Sell
56
-24
-30% -$680 ﹤0.01% 1494
2024
Q1 		$2.39K Buy
+80
New +$2.35K ﹤0.01% 1272

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Bell Investment Advisors's GMAB Position: Q2 2026 in Review

Bell Investment Advisors reduced its Genmab (GMAB) stake by 90% in Q2 2026, selling an estimated $8.05K and leaving 33 shares worth $907. The position accounts for ﹤0.01% of the portfolio, ranked #1552.

Bell Investment Advisors first reported a position in GMAB in Q1 2024 and has held it in 10 quarters since. The position peaked at $9.02K in Q1 2026. 290 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Bell Investment Advisors held 33 shares of Genmab worth $907 as of Q2 2026.
  • Bell Investment Advisors sold 303 Genmab shares in Q2 2026, an estimated $8.05K.
  • Genmab made up ﹤0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #1552 holding.
  • Bell Investment Advisors first reported a position in Genmab in Q1 2024 and has held it in 10 quarters since.
  • Bell Investment Advisors's Genmab position peaked at $9.02K in Q1 2026.
  • 290 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.